ArticleEuropean radiology2025
Overlooked and underpowered: a meta-research addressing sample size in radiomics prediction models for binary outcomes.
Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Article
- Externally validated yet undertrained: sample size deficits in machine learning-based radiomics.European radiology · 2026Article
- Radiomics and Artificial Intelligence in Ovarian Endometriosis Imaging: A Systematic Review and Critical Appraisal of Emerging Evidence.Bioengineering (Basel, Switzerland) · 2026Review
- Why Radiomics Rarely Reaches the Clinic: Reproducibility, Validation, and Evidence Gap-A Critical Narrative Review.Diagnostics (Basel, Switzerland) · 2026Review
- Radiomics and Back Pain.Global spine journal · 2026Review
- Radiomic analysis of medical imaging for classification in oncology and recommendations for clinically initiated research: a literature review.Quantitative imaging in medicine and surgery · 2026Review
- Current applications of radiomics in neurotrauma.Neurosurgical review · 2026Review
- Predictive imaging in abdominal oncology: current trends and future directions.Japanese journal of radiology · 2026Review
- Artificial intelligence-driven body composition analysis and its association with survival in patients with colorectal liver metastases.Contemporary oncology (Poznan, Poland) · 2026Article
- A Noninvasive Predictive Model of Portal Hypertension in Patients with HCC Based on Clinical Features and Intra- and Peritumoral Pre-Fusion Radiomic Features.Journal of hepatocellular carcinoma · 2026Article
- Combined clinical and DWI radiomics model for predicting 90-day functional outcomes after intravenous thrombolysis in acute ischemic stroke patients.Frontiers in neurology · 2026Article
- Machine learning-based clinical-radiomics model for predicting recurrence risk after radical surgery in sinonasal squamous cell carcinoma: a preliminary 2-year follow-up study.BMC medical imaging · 2025Article
- Rethinking feature reproducibility in radiomics: the elephant in the dark.European radiology experimental · 2025Article
- Development and validation of a nomogram for diabetic tibial neuropathy based on ultrasound radiomics: a multicenter study.BMC medical imaging · 2025Article
- Explanation and Elaboration with Examples for METRICS (METRICS-E3): an initiative from the EuSoMII Radiomics Auditing Group.Insights into imaging · 2025Article
- Hybrid Radiomics and Machine Learning for Brain Tumors Multi-Task Classification: An Exploratory Study on Integrating GLCM and Curvelet-Based Features for Enhanced Accuracy.Health science reports · 2025Article
- Computed tomography-based radiomics model for predicting station 4 lymph node metastasis in non-small cell lung cancer.BMC medical imaging · 2025Article
- MRI in Oral Tongue Squamous Cell Carcinoma: A Radiomic Approach in the Local Recurrence Evaluation.Current oncology (Toronto, Ont.) · 2025Article
- Scoping review of image-based overall survival prediction in glioma using machine learning.Polish journal of radiology · 2025Review
Corrections and comments
- Commented on by
Authors and funding
19 authors.
Funding
Abstract
objectivesTo investigate how studies determine the sample size when developing radiomics prediction models for binary outcomes, and whether the sample size meets the estimates obtained by using established criteria.
methodsWe identified radiomics studies that were published from 01 January 2023 to 31 December 2023 in seven leading peer-reviewed radiological journals. We reviewed the sample size justification methods, and actual sample size used. We calculated and compared the actual sample size used to the estimates obtained by using three established criteria proposed by Riley et al. We investigated which characteristics factors were associated with the sufficient sample size that meets the estimates obtained by using established criteria proposed by Riley et al.
resultsWe included 116 studies. Eleven out of one hundred sixteen studies justified the sample size, in which 6/11 performed a priori sample size calculation. The median (first and third quartile, Q1, Q3) of the total sample size is 223 (130, 463), and those of sample size for training are 150 (90, 288). The median (Q1, Q3) difference between total sample size and minimum sample size according to established criteria are -100 (-216, 183), and those differences between total sample size and a more restrictive approach based on established criteria are -268 (-427, -157). The presence of external testing and the specialty of the topic were associated with sufficient sample size.
conclusionRadiomics studies are often designed without sample size justification, whose sample size may be too small to avoid overfitting. Sample size justification is encouraged when developing a radiomics model. KEY POINTS: Question Sample size justification is critical to help minimize overfitting in developing a radiomics model, but is overlooked and underpowered in radiomics research. Findings Few of the radiomics models justified, calculated, or reported their sample size, and most of them did not meet the recent formal sample size criteria. Clinical relevance Radiomics models are often designed without sample size justification. Consequently, many models are too small to avoid overfitting. It should be encouraged to justify, perform, and report the considerations on sample size when developing radiomics models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.